论文部分内容阅读
1前言乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染在肝细胞癌(HCC)的发生发展中起重要作用。我国近年发布的《慢性乙型肝炎防治指南(2010版)》和《原发性肝癌诊疗规范(2011版)》都强调了肝癌患者抗病毒治疗的重要性,《丙型肝炎防治指南(2004版)》也注意到抗病毒治疗可延缓HCC的发生。目前国内外对肝癌抗病毒治疗的具体实施和评价尚无统一认识。有鉴于此,中华医学会肝病学
1 Introduction Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection play an important role in the development of hepatocellular carcinoma (HCC). In recent years, China has emphasized the importance of antiviral treatment for patients with liver cancer, Guidelines for Prevention and Treatment of Chronic Hepatitis B (2010 Edition) and Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2011 Edition) ) "It is also noted that antiviral therapy can delay the onset of HCC. At present, there is no uniform understanding of the specific implementation and evaluation of anti-virus treatment of liver cancer at home and abroad. In view of this, Chinese Medical Association hepatology